Pandemic E. coli strain H30 cloaks its stealth strategies

April 19, 2016
An electron micrograph of a single E. coli bacterium of the pandemic H30 strain. The pathogen, which largely infects the urinary tract, can cause mild or no symptoms, but later serious complications might set in. H30 E. coli infections are more common in the elderly. Credit: Dagmara Kisiela/Univeristy of Washington

The difficulty in subduing the pandemic strain of drug-resistant E. coli, called H30, may go beyond patient vulnerability or antibiotic resistance. This form of the disease-pathogen may have an intrinsic ability to cause persistent, harmful, even deadly infections.

The bacterium E. coli comes in many different varieties. Many strains live unobtrusively in the gut or innocuously in the environment. Some strains can cause diarrhea. Others can invade the , the blood stream, or other parts of the body to provoke varying degrees of illness, from mild to serious and sometimes fatal.

A particular genetic family of E. coli, Sequence Type 131, produced the H30 strain, which appeared in late 1990s. In an almost unprecedented show of microbial force, it expanded around the world to become the dominant drug-resistant strain in virtually all populations.

"No other type of E. coli is causing this much widespread damage," said Evgeni Sokurenko, University of Washington professor of microbiology. "We need to pay as much attention to it as we do to the superbug MRSA, the treatment-resistant staph ."

To make matters worse, H30 begins as a subtle infection that is hard to detect, he explained.

Once diagnosed, even if the right antibiotic is given, physicians have trouble eradicating the infection, and complications can set in.

The power of the H30 strain, and why it has become so common, is puzzling. According to Sokurenko, most animal studies have failed to confirm that the H30 strain is especially virulent. It has also been assumed that H30 causes opportunistic infections, by taking advantage of the rapidly growing elderly population and others with weakened immune systems.

An electron micrograph of an E. coli H30, a pandemic strain of the pathogen. H30 has spread around the world and is now the dominant drug-resistant strain in almost all populations Credit: Dagmara Kisiela/University of Washington

It is also thought that broad-spectrum antibiotic use might have promoted H30's dominance by making it resistant to several drugs, particularly the fluoroquinolones (such as Cipro), which are widely prescribed for .

These factors, as well as possible presence of as yet-unknown pathogen traits, could have contributed to H30's emergence as a public health problem. Each year in the United States alone, H30 may cause more than 1 million urinary tract infections, as well as much more lethal blood infections.

Sokurenko is one of the leaders of a team of researchers from the University of Washington, the Minneapolis Veterans Affairs Health Care System, the University of Minnesota, Seattle Children's Hospital and Group Health Cooperative to assess the nature of H30 infections.

Analyzing epidemiological and medical data, the team explored possible associations of H30 with patient characteristics, clinical manifestations, treatment, and how well or poorly the patients fared.

Their findings are published in the journal, Clinical Infectious Diseases. James R. Johnson, staff physician and director of the Molecular Epidemiology Unit at the Minneapolis VA Health Care System, and professor of medicine at the University of Minnesota, was the lead author of the study.

The researchers found that individuals at greater risk for E. coli H30 infection tended to be older women and men who had been in a healthcare facility, including long term care residences or hospitals, who had received antibiotics, and who had underlying conditions that weakened their ability to ward off infections.

The researchers also observed that patients who were later shown to have H30 were, at their first visit with the doctor, significantly less likely to be suspected of having an infection, and less likely to receive a proper antibiotic prescription.

An electron micrograph of the H30 pandemic strain E. coli. It is often a urinary tract pathogen, but also can infect the blood stream and other areas. Credit: Dagmara Kisiela /University of Washington

Within a month afterward, patients whose initial strain was H30 were more likely to experience a severe complication, including a hospital admission or a new infection at a different site.

Thus, the researchers reported that H30 "was strongly associated with ineffective initial antimicrobial therapy, clinical and microbial persistence, and diverse, later-occurring adverse effects."

And even when the H30 infection seemed like any other E. coli infection during the first clinical encounter, and the patient received a correct antibiotic, the infection could persist for an unusually long time.

"We don't know the exact reason, but it's possible that H30 might have been hiding from the patients' natural defenses against infection, thereby impairing the body's attempt to clear the pathogen during treatment," Sokurenko said.

"Distinctive properties that perhaps allow H30 to act as a defenses-evading pathogen might also be associated with the delayed complications," he surmised.

He added that the basis for the lack of response to supposedly effective antibiotic treatment and reasons for later-appearing complications is still unclear.

"H30 might have that dangerous combination of being both highly resistant to antibiotics and highly successful as a stealth pathogen," Sokurenko said. "This double-trouble may be why H30 is so widespread and has become a superbug. What makes it worse is that can go unnoticed in a patient until it causes significant damage."

Sokurenko would like to see better ways to anticipate, detect, and diagnose H30 in the elderly or other vulnerable patients who don't have the usual symptoms of urinary tract or bloodstream infection.

In addition to improved surveillance, he also would like rapid tests to become available to determine which antibiotics may or may not work for an individual patient, to avoid antibiotic-bacteria mismatch and delayed treatment response.

"Our findings reinforce the need for a more 'individualized medicine' approach to prescribing antibiotics for E. coli infections," he said. "Also, even if the infection seems mild the patient should be monitored carefully so it does not progress unchecked."

The other authors of the study were Paul Thuras, Brian D. Johnston, Scott J. Weissman, Ajit P. Limaye, Kim Riddell, Delia Scholes, and Veronika Tchesnokova.

Three of the researchers have patent applications pending for tests for E. coli H30 strain. Sokurenko also is a founder and a major shareholder in ID Genomics.

Explore further: Epidemic of Escherichia coli infections traced to one strain of bacteria

More information: James R. Johnson et al. The Pandemic 30 Subclone of Sequence Type 131 (ST131) is Associated with Persistent Infections and Adverse Outcomes Independently from Its Multi-Drug Resistance and Associations with Compromised Hosts , Clinical Infectious Diseases (2016). DOI: 10.1093/cid/ciw193

Related Stories

Epidemic of Escherichia coli infections traced to one strain of bacteria

December 17, 2013
In the past decade, a single strain of Escherichia coli, or E. coli, has become the main cause of bacterial infections in women and the elderly by invading the bladder and kidneys, according to a study published today in ...

Antibiotic-resistant strain of E. coli increasing among older adults and residents of nursing homes

March 12, 2013
Antibiotic-resistant Escherichia coli (E. coli) continues to proliferate, driven largely by expansion of a strain of E. coli know as sequence type ST131. A new study points to hospitals and long-term care facilities (LTCF) ...

Antibiotic resistance in children is high and associated with previous antibiotic use

March 15, 2016
Antibiotic resistance in children with urinary infections is high and could render some antibiotics ineffective as first-line treatments, warns a study published by The BMJ today.

Pre-op back pain, pain sensitivity predict outcomes

January 26, 2015
(HealthDay)—Preoperative back pain and individual pain sensitivity can predict postoperative pain following lumbar surgery, according to a study published in the December issue of Pain Medicine.

Number of patients admitted with antibiotic-resistant infections rising

March 25, 2014
The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published ...

Drug-resistant E. coli continues to climb in community health settings

October 13, 2015
Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.

Recommended for you

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.